BCM
TMDX icon

BlueCrest Capital Management’s Transmedics TMDX Stock Holding History

BlueCrest Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,000
Closed -$227K – 331
2023
Q1 		$227K Buy
+3,000
New +$207K 0.01% 245

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return

BlueCrest Capital Management's TMDX Position: Q2 2023 in Review

BlueCrest Capital Management sold out of Transmedics (TMDX) in Q2 2023, closing a stake of 3,000 shares — an estimated $227K sold.

BlueCrest Capital Management first reported a position in TMDX in Q1 2023 and held it in 1 quarter. The position peaked at $227K in Q1 2023. 240 funds tracked by Wall St. Rank hold TMDX as of Q2 2023.

  • BlueCrest Capital Management reported no remaining Transmedics position as of Q2 2023 after selling out during the quarter.
  • BlueCrest Capital Management sold 3,000 Transmedics shares in Q2 2023, an estimated $227K.
  • BlueCrest Capital Management first reported a position in Transmedics in Q1 2023 and held it in 1 quarter.
  • BlueCrest Capital Management's Transmedics position peaked at $227K in Q1 2023.
  • 240 funds tracked by Wall St. Rank held Transmedics as of Q2 2023.

Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.